GlassScriptPhysician profile
Kylee Dee Johnson
NPI 1538636121
$3,372.32
in general payments reported to CMS, 2019-2025
9 companies · $1,909 in 2025
The $1,909 reported for 2025 was more than what 93% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $175 · 2023: $35.32 · 2024: $1,253 · 2025: $1,909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,248 · Food and Beverage: $949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,248.14 |
| Food and Beverage | $949.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $2,845.86 | 2024-2025 | Bd Max System, Bd Max Instrument, Bd Onclarity |
| Abbvie INC. | $271.65 | 2022-2024 | |
| Astellas Pharma US INC | $102.91 | 2024 | Veozah |
| Boston Scientific Corporation | $48.20 | 2022-2024 | |
| Galderma Laboratories, L.P. | $31.58 | 2024-2025 | Dysport |
| Mayne Pharma Commercial LLC | $25.15 | 2023-2025 | |
| Revance Therapeutics, INC. | $17.57 | 2025 | Daxxify |
| Lilly USA, LLC | $16.15 | 2024 | Zepbound |
| Coopersurgical, INC. | $13.25 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kylee Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.